Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy. [electronic resource]
Producer: 19961107Description: 173-8 p. digitalISSN:- 0960-8931
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.